Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study-Reference-Cited by-同舟云学术

Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study

Published:2020-03-31 Issue: Volume:7 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Feng Yimei,Xiao Yunshuo,Yan Hongju,Wang Ping,Zhu Wen,Cassady Kaniel,Zou Zhongmin,Wang Kaifa,Chen Ting,Quan Yao,Wang Zheng,Yang Shijie,Wang Rui,Li Xiaoping,Gao Lei,Zhang Cheng,Liu Yao,Kong Peiyan,Gao Li,Zhang Xi

Funder

Natural Science Foundation of Chongqing

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

General Medicine

Reference30 articles.

1. How I treat refractory immune thrombocytopenia;Cuker;Blood.,2016

2. Developing role of B cells in the pathogenesis and treatment of chronic GVHD;Li;Br J Haematol.,2019

3. mTOR as Regulator of Lifespan, aging, and cellular senescence: a mini-review;Weichhart;Gerontology.,2018

4. Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease;Villa;Biol Blood Marrow Transplant.,2015

5. Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome;Teachey;Br J Haematol.,2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of thrombocytopenia with immune checkpoint inhibitors: a large-scale pharmacovigilance analysis based on the data from FDA adverse event reporting system database;Frontiers in Pharmacology;2024-06-17

2. Sirolimus is effective and safe in childhood relapsed‐refractory autoimmune cytopenias: A multicentre study;Scandinavian Journal of Immunology;2024-05-13

3. Identification of metabolism-related key genes as potential biomarkers for pathogenesis of immune thrombocytopenia;Scientific Reports;2024-04-19

4. Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study;Blood Coagulation & Fibrinolysis;2024-04-15

5. Optimizing the therapeutic window of sirolimus by monitoring blood concentration for the treatment of immune thrombocytopenia;Platelets;2023-11-20